Edimer Pharmaceuticals Report issue

For profit Phase 2
Founded: Cambridge MA United States (2009)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2012
NCT01564225
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

edi200 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ectodermal Dysplasia (Phase 2)

Ectodermal Dysplasia 1, Anhidrotic (Phase 2)

Hyperplasia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1